Prostate Screening Choices
- Both benign and cancerous conditions can cause elevated PSA levels.
- The blood test can only measure the levels, not the cause. Further testing would need to be done to find the cause.
- Prostate cancer does not always increase PSA levels. A test that shows normal levels does not mean you are cancer-free. Do not ignore symptoms common to prostate cancer because you had a normal PSA test. This could lead to a delay in treatment.
Digital Rectal Exam
- The DRE cannot show if the lump is cancer or not. A positive test will lead to further testing.
- Some lumps may not be found through this exam. Very early stage cancer is difficult to detect with DRE. A clear test (where the doctor does not detect any lumps) may again encourage men to ignore symptoms common to prostate cancer. This could lead to delays in treatment.
American Cancer Society http://www.cancer.org/
National Cancer Institute http://www.cancer.gov/
National Prostate Cancer Coalition http://www.pcacoalition.org/
The Canadian Prostate Cancer Network http://www.cpcn.org/
Prostate Cancer Research Foundation http://www.prostatecancer.ca/
Can prostate cancer be found early? American Cancer website. Available at: http://www.cancer.org/docroot/cri/content/cri%5F2%5F4%5F3x%5Fcan%5Fprostate%5Fcancer%5Fbe%5Ffound%5Fearly%5F36.asp . Accessed January 26, 2010.
Early prostate cancer. National Cancer Institute website. http://www.cancer.gov/cancertopics/factsheet/Detection/early-prostate . Accessed January 26, 2010.
Prostate cancer. EBSCO Health Library website. Available at: http://www.ebscohost.com/healthLibrary/. Accessed January 21, 2010.
Prostate cancer screening. EBSCO DynaMed website. Available at: http://www.ebscohost.com/healthLibrary/. April 23, 2012. Accessed April 24, 2012.
Prostate-specific antigen (PSA) test. EBSCO Health Library website. Available at:http://www.ebscohost.com/healthLibrary/. Accessed January 26, 2010.
10/26/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010;11(8):725-732.
- Reviewer: Peter J. Lucas, MD
- Review Date: 05/2012 -
- Update Date: 05/07/2012 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.